BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29569698)

  • 1. Expression of microRNA-145, OCT4, and SOX2 in double primary endometrioid endometrial and ovarian carcinomas.
    Zhang R; Jiao J; Chu H; Yang H; Wang L; Gao N
    Histol Histopathol; 2018 Aug; 33(8):859-870. PubMed ID: 29569698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
    Soovares P; Pasanen A; Bützow R; Lassus H
    Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading.
    Pityński K; Banas T; Pietrus M; Milian-Ciesielska K; Ludwin A; Okon K
    Int J Clin Exp Pathol; 2015; 8(7):8189-98. PubMed ID: 26339387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
    Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D
    Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.
    Anglesio MS; Wang YK; Maassen M; Horlings HM; Bashashati A; Senz J; Mackenzie R; Grewal DS; Li-Chang H; Karnezis AN; Sheffield BS; McConechy MK; Kommoss F; Taran FA; Staebler A; Shah SP; Wallwiener D; Brucker S; Gilks CB; Kommoss S; Huntsman DG
    J Natl Cancer Inst; 2016 Jun; 108(6):djv428. PubMed ID: 26832771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
    Werner HM; Berg A; Wik E; Birkeland E; Krakstad C; Kusonmano K; Petersen K; Kalland KH; Oyan AM; Akslen LA; Trovik J; Salvesen HB
    Mod Pathol; 2013 Mar; 26(3):428-34. PubMed ID: 23080032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma.
    Ji J; Wei X; Wang Y
    Int J Clin Exp Pathol; 2014; 7(5):2470-6. PubMed ID: 24966958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology.
    Chao A; Wu RC; Jung SM; Lee YS; Chen SJ; Lu YL; Tsai CL; Lin CY; Tang YH; Chen MY; Huang HJ; Chou HH; Huang KG; Chang TC; Wang TH; Lai CH
    Gynecol Oncol; 2016 Oct; 143(1):60-67. PubMed ID: 27498588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa.
    Qiao B; He B; Cai J; Yang W
    Int J Clin Exp Pathol; 2014; 7(1):28-37. PubMed ID: 24427323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
    Schultheis AM; Ng CK; De Filippo MR; Piscuoglio S; Macedo GS; Gatius S; Perez Mies B; Soslow RA; Lim RS; Viale A; Huberman KH; Palacios JC; Reis-Filho JS; Matias-Guiu X; Weigelt B
    J Natl Cancer Inst; 2016 Jun; 108(6):djv427. PubMed ID: 26832770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
    Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
    Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
    Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
    Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
    J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
    Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
    Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
    Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
    Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
    Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
    Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
    Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
    Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.